ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2033

Clinical Manifestations Associated with Peripheral Joint Involvement in Patients with Acute Chikungunya Virus Infection

Mariangelí Arroyo-Ávila1, Amanda Cabán2, Marisela Irizarry-Pérez3, Hilda Torres3, Enid J. García3, Héctor Gorbea4 and Luis M. Vilá1, 1Department of Medicine, Division of Rheumatology, University of Puerto Rico Medical Sciences Campus, San Juan, PR, 2Department of Medicine, University of Puerto Rico Medical Sciences Campus, San Juan, PR, 3School of Medicine, Endowed Health Services Research Center, University of Puerto Rico Medical Sciences Campus, San Juan, PR, 4Department of Medicine, Division of Infectious Diseases, University of Puerto Rico Medical Sciences Campus, San Juan, PR

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: arthritis and viruses, Hispanic patients

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Infection-related Rheumatic Disease

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Chikungunya
virus (CHIKV) infection causes an acute febrile illness usually accompanied by
severe polyarthralgia and polyarthritis.  Previous studies have shown that older age, female
gender and some comorbid conditions are associated with chronic arthritis.  However, the factors associated with acute arthralgia or arthritis are not
well known.  Thus, we studied the
clinical manifestations associated with acute peripheral arthralgia/arthritis
in a group of CHIKV patients from Puerto Rico.

Methods: As part of an acute
febrile illness surveillance project, patients with fever or history of fever
for ≤ 7 days evaluated at the emergency room of a community hospital
in Puerto Rico were tested for several pathogens including CHIKV. All patients with
positive CHIKV testing by either polymerase chain reaction
or IgM enzyme-linked immunosorbent assays from June
2014 to September 2014 were studied.  Demographic
features, clinical manifestations, and comorbidities were determined. Patients
with peripheral arthralgia and/or arthritis were
compared to those without peripheral joint symptoms. To examine the differences
between the study groups we used bivariable and
multivariable analyses adjusting for confounding variables.

Results: In total, 172 patients with CHIKV infection were
evaluated, of which 52.9% were female. The mean (standard deviation [SD]) age
was 21.1 (± 19.3); 65.5% were
≤ 16 years of age, 25.7% were 17–54 years of age, and 8.8% were ≥ 55
years of age. Peripheral arthralgia/arthritis were
seen in 156 (90.7%) patients, of whom 49 (31.4%) had signs of synovitis. In the
bivariable analysis, patients with CHIKV
arthralgias/arthritis were more likely to be older (21.3 [± 19.6] years vs. 8.2 [± 10.3] years, p < 0.01) and to have more myalgias (85.9% vs. 50.0%, p < 0.01), back pain (63.5% vs. 6.2%,
p < 0.01), headaches (87.2% vs.
50.0%, p < 0.01), orbital pain
(47.4% vs. 6.2%, p < 0.01), anorexia
(71.8% vs. 37.5%, p < 0.01), nausea
(62.8% vs. 18.8%, p < 0.01), and
dizziness (48.1% vs. 12.5%, p < 0.01)
than those without with peripheral joint involvement. No associations were
found for gender, rash, pulmonary symptoms, cardiac manifestations, vomiting,
diarrhea, abdominal pain, hematologic abnormalities,
elevation of liver enzymes, renal manifestations, or comorbidities such as
diabetes, hypertension, cardiac disease, asthma, chronic kidney disease and
malignancy. The multivariable analysis is shown in the table.

    Clinical manifestations associated with
acute peripheral arthralgias/arthritis

Clinical features

OR (95% CI)

p value

Myalgias

4.65 (1.48 – 14.72)

<0.01

Back pain

16.77 (3.07 – 313.82)

<0.01

Headache

3.63 (1.06 – 12.53)

<0.05

Ocular pain

8.88 (1.65 – 165.19)

<0.05

Anorexia

5.68 (1.87 – 18.97)

<0.01

Nausea

6.88 (2.05 – 31.49)

<0.01

Dizziness

4.07 (0.98 – 27.69)

0.10

Conclusion: In this
population of patients with acute CHIKV infection, peripheral joint involvement
was associated with myalgias and back pain as well as non musculoskeletal
manifestations such as headaches, ocular pain, anorexia and nausea. Clinicians
should be aware that this constellation of symptoms is common in these
patients.


Disclosure: M. Arroyo-Ávila, None; A. Cabán, None; M. Irizarry-Pérez, None; H. Torres, None; E. J. García, None; H. Gorbea, None; L. M. Vilá, None.

To cite this abstract in AMA style:

Arroyo-Ávila M, Cabán A, Irizarry-Pérez M, Torres H, García EJ, Gorbea H, Vilá LM. Clinical Manifestations Associated with Peripheral Joint Involvement in Patients with Acute Chikungunya Virus Infection [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/clinical-manifestations-associated-with-peripheral-joint-involvement-in-patients-with-acute-chikungunya-virus-infection/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-manifestations-associated-with-peripheral-joint-involvement-in-patients-with-acute-chikungunya-virus-infection/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology